1
|
Affiliation(s)
- G L Quaglio
- European Parliamentary Research Services (EPRS), European Parliament, Brussels, Belgium.
| | - W Preiser
- Division of Medical Virology, Faculty of Medicine & Health Sciences, Stellenbosch University and National Health Laboratory Service Tygerberg, Cape Town, South Africa
| | - G Putoto
- Operational Research Unit, Doctors with Africa CUAMM, Padua, Italy
| |
Collapse
|
2
|
Zachariah R, Kumar AMV, Reid AJ, Van den Bergh R, Isaakidis P, Draguez B, Delaunois P, Nagaraja SB, Ramsay A, Reeder JC, Denisiuk O, Ali E, Khogali M, Hinderaker SG, Kosgei RJ, van Griensven J, Quaglio GL, Maher D, Billo NE, Terry RF, Harries AD. Open access for operational research publications from low- and middle-income countries: who pays? Public Health Action 2015; 4:142-4. [PMID: 26400799 DOI: 10.5588/pha.14.0028] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2014] [Accepted: 05/13/2014] [Indexed: 11/10/2022] Open
Abstract
Open-access journal publications aim to ensure that new knowledge is widely disseminated and made freely accessible in a timely manner so that it can be used to improve people's health, particularly those in low- and middle-income countries. In this paper, we briefly explain the differences between closed- and open-access journals, including the evolving idea of the 'open-access spectrum'. We highlight the potential benefits of supporting open access for operational research, and discuss the conundrum and ways forward as regards who pays for open access.
Collapse
Affiliation(s)
- R Zachariah
- Médecins Sans Frontières (MSF), Operational Centre Brussels, Medical Department, Operations Research Unit (LUXOR), MSF-Luxembourg, Luxembourg
| | - A M V Kumar
- International Union Against Tuberculosis and Lung Disease (The Union), South-East Asia Office, New Delhi, India
| | - A J Reid
- Médecins Sans Frontières (MSF), Operational Centre Brussels, Medical Department, Operations Research Unit (LUXOR), MSF-Luxembourg, Luxembourg
| | - R Van den Bergh
- Médecins Sans Frontières (MSF), Operational Centre Brussels, Medical Department, Operations Research Unit (LUXOR), MSF-Luxembourg, Luxembourg
| | | | - B Draguez
- MSF, Medical Department, Brussels Operational Center, Belgium
| | - P Delaunois
- MSF, General Direction, Luxembourg, Luxembourg
| | - S B Nagaraja
- Department of Community Medicine, Employees State Insurance Corporation Medical College and Post Graduate Institute of Medical Sciences and Research, Bangalore, India
| | - A Ramsay
- United Nations Children's Fund/United Nations Development Programme/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases, World Health Organization, Geneva, Switzerland ; University of St Andrews Medical School, Scotland, UK
| | - J C Reeder
- United Nations Children's Fund/United Nations Development Programme/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases, World Health Organization, Geneva, Switzerland
| | - O Denisiuk
- International HIV/AIDS Alliance, Kyiv, Ukraine
| | - E Ali
- Médecins Sans Frontières (MSF), Operational Centre Brussels, Medical Department, Operations Research Unit (LUXOR), MSF-Luxembourg, Luxembourg
| | - M Khogali
- Médecins Sans Frontières (MSF), Operational Centre Brussels, Medical Department, Operations Research Unit (LUXOR), MSF-Luxembourg, Luxembourg
| | - S G Hinderaker
- Centre for International Health, University of Bergen, Bergen, Norway
| | - R J Kosgei
- University of Nairobi, Obstetrics and Gynecology, Nairobi, Kenya
| | | | - G L Quaglio
- Science and Technology Option Assessment (STOA), Directorate-General for Parliamentary Research Services (EPRS), European Parliament, Brussels, Belgium
| | | | - N E Billo
- The Union, Centre for Operational Research, Paris, France
| | - R F Terry
- United Nations Children's Fund/United Nations Development Programme/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases, World Health Organization, Geneva, Switzerland
| | - A D Harries
- The Union, Centre for Operational Research, Paris, France ; London School of Hygiene & Tropical Medicine, London, UK
| |
Collapse
|
3
|
Lugoboni F, Faccini M, Quaglio GL, Albiero A, Casari R, Pajusco B. Intravenous flumazenil infusion to treat benzodiazepine dependence should be performed in the inpatient clinical setting for high risk of seizure. J Psychopharmacol 2011; 25:848-9. [PMID: 21262854 DOI: 10.1177/0269881110393050] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Affiliation(s)
- F Lugoboni
- Department of Internal Medicine, Addiction Unit, Verona University Hospital, Verona, Italy
| | - M Faccini
- Department of Internal Medicine, Addiction Unit, Verona University Hospital, Verona, Italy
| | - GL Quaglio
- Department of Internal Medicine, Addiction Unit, Verona University Hospital, Verona, Italy
| | - A Albiero
- Department of Internal Medicine, Addiction Unit, Verona University Hospital, Verona, Italy
| | - R Casari
- Department of Internal Medicine, Addiction Unit, Verona University Hospital, Verona, Italy
| | - B Pajusco
- Department of Internal Medicine, Addiction Unit, Verona University Hospital, Verona, Italy
| |
Collapse
|
4
|
Quaglio GL, Pattaro C, Ramadani N, Bertinato L, Elezi Y, Dentico P, Volpe A, Ciotti M, Rezza G, Putoto G. Viral hepatitis, HIV, human herpes virus and Treponema pallidum infection in haemodialysis patients from Kosovo, 2005. Euro Surveill 2009; 14:19439. [PMID: 20003903] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2023] Open
Abstract
The serological status of hepatitis viruses and other infectious diseases in the 66 dialysed patients of one haemodialysis unit in Kosovo were studied, comparing the data with a large group of blood donors and out-patients. All dialysed patients were hepatitis A virus (HAV) positive. Prevalence of hepatitis B surface antigen (HBsAg), hepatitis B surface antibodies (anti-HBs), and hepatitis B core antibodies (anti-HBc) was 14 of 66, 21% (95% confidence interval (CI): 12-33%), 5 of 66, 8% (95%CI: 5-22%), and 50 of 66, 76% (95%CI: 64-85%), respectively. Antibodies to hepatitis C virus (anti-HCV) prevalence was 57 of 66, 86% (95%CI: 76-94%). No human immunodeficiency virus (HIV) positive case was found. Prevalence of past herpes simplex virus type 2 (HSV-2) infection was 29% (95%CI: 18-41%). Two patients (3%, 95%CI: 0-10%) were positive for Treponema pallidum and 18% (95%CI: 10-30%) were human herpesvirus 8 (HHV-8) antibody positive. Four hundred and fifty-two subjects were recruited for comparison. Markers of past HAV infection was associated with haemodialysis (Fisher s exact test p-value=0.037). Dialysed patients were at a higher risk of being HBsAg positive than others: the sex- and age-adjusted odds ratio (OR) was 5.18 (95%CI: 1.87-14.32). Anti-HBc positivity was strongly associated with haemodialysis: the sex- and age-adjusted OR was 6.43 (95%CI: 3.22-12-85). Anti-HCV positivity was 86% and 1% in presence and absence of haemodialysis, respectively. The Fisher s exact test for association proved a strong association between haemodialysis and HCV (p-value<0.0001). The OR for association between haemodialysis and HSV-2 positivity was 3.20 (95%CI: 1.46-7.00). Significant associations were also observed between haemodialysis status and antibodies to Treponema pallidum (Fisher s exact test p-value=0.044). In Kosovo, the prevalence of viral hepatitis infection and other viral infections and Treponema pallidum among dialysed patients is high, indicating major ongoing nosocomial transmission.
Collapse
Affiliation(s)
- G L Quaglio
- Veneto Region, Italian Co-operation, Peja Training Project Team, Venice, Italy.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Quaglio GL, Pattaro C, Ramadani N, Bertinato L, Elezi Y, Dentico P, Volpe A, Ciotti M, Rezza G, Putoto G. Viral hepatitis, HIV, human herpes virus and Treponema pallidum infection in haemodialysis patients from Kosovo, 2005. Euro Surveill 2009. [DOI: 10.2807/ese.14.49.19439-en] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Binary file ES_Abstracts_Final_ECDC.txt matches
Collapse
Affiliation(s)
- G L Quaglio
- Veneto Region, Italian Co-operation, Peja Training Project Team, Venice, Italy
| | - C Pattaro
- European Academy (EURAC), Bozen/Bolzano, Italy - Affiliated Institute of the University Lübeck, Germany
| | - N Ramadani
- National Institute of Public Health, Pristhine, Kosovo
| | - L Bertinato
- Veneto Region, Italian Co-operation, Peja Training Project Team, Venice, Italy
| | - Y Elezi
- Nephrology Unit, Department of Internal Medicine, University of Prishtine, Kosovo
| | - P Dentico
- Institute of Internal Medicine, University of Bari, Italy
| | - A Volpe
- Institute of Internal Medicine, University of Bari, Italy
| | - M Ciotti
- European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
| | - G Rezza
- Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy
| | - G Putoto
- Veneto Region, Italian Co-operation, Peja Training Project Team, Venice, Italy
| |
Collapse
|
6
|
Quaglio GL, Lugoboni F, Pajusco B, Sarti M, Talamini G, Mezzelani P, Des Jarlais DC. Hepatitis C virus infection: prevalence, predictor variables and prevention opportunities among drug users in Italy. J Viral Hepat 2003; 10:394-400. [PMID: 12969192 DOI: 10.1046/j.1365-2893.2003.00448.x] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
The study assessed rates and predictor variables of hepatitis C virus (HCV) infection among drug users receiving pharmacological treatment for opiates addiction. There was a large cohort study in 16 public centres for drug users in north-eastern Italy, with data collected by standardized face-to-face interviews between February 2001 and August 2001. Of 1095 participants, 74.2% were HCV seropositive. Anti-HCV status was independently associated with duration of drug use of over 10 years, injecting as a route of drug administration, and hepatitis B virus (HBV) and human immunodeficiency virus (HIV) seropositivity. Further statistical analysis was conducted by dividing the subjects on the basis of the duration of heroin use: more or <10 years. In the multivariate analyses, route of drug administration and HBV status were associated with HCV seropositivity among both groups. Less education was associated with HCV among the shorter term drug users. HIV status and having a sexual partner with a history of drug use were associated with HCV seropositivity among the longer term drug users. Half of the short-term heroin users were still HCV seronegative when starting treatment, suggesting opportunities for reducing new HCV infections. Remarkable was the relationship between vaccination for hepatitis B and HCV serostatus. Being HBV seropositive was strongly associated with being HCV seropositive. But heroin users who had been vaccinated for HBV were not significantly more likely to be HCV seropositive than heroin users who were HBV seronegative. HBV vaccination does not provide biological protection against HCV; however, vaccinating heroin users against HBV may help to create a stronger pro-health attitude among heroin users, leading to a reduction in HCV risk behaviour.
Collapse
Affiliation(s)
- G L Quaglio
- Medical Service for Addictive Disorders, Department of Internal Medicine, University of Verona, Verona, Italy.
| | | | | | | | | | | | | |
Collapse
|
7
|
|
8
|
Mezzelani P, Quaglio GL, Venturini L, Lugoboni F, Friedman SR, Des Jarlais DC. A multicentre study on the causes of death among Italian injecting drug users. AIDS has overtaken overdose as the principal cause of death. AIDS Care 1998; 10:61-7. [PMID: 9536202 DOI: 10.1080/713612356] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
The causes of death among injecting drug users. (IDUs) are still being discussed worldwide. We analysed the causes of death among IDUs attending 26 centres for drug users in North-Eastern Italy from 1985 to 1994. The study of a total number of 1,022 deaths reveals the following: (1) AIDS has become the primary cause of death among IDUs since 1991 and is rising even in an area with a moderate HIV seroprevalence; (2) the mean age of death in AIDS patients proved higher than among patients who died of other causes (which may be due to the long incubation period of AIDS); (3) our data do not reveal higher HIV seroprevalence among IDUs who died of overdose and suicide as opposed to IDUs who died of other causes; (4) the mortality rate in IDUs is significantly higher when compared to that of the general population in the same age group.
Collapse
Affiliation(s)
- P Mezzelani
- Institute of Clinica Medica, University of Verona, Italy.
| | | | | | | | | | | |
Collapse
|
9
|
|
10
|
Quaglio GL, Lombardi D, Franchini A. [Immune response to vaccination with live Newcastle disease virus and killed emulsified virus in chicks without specific parental antibodies or with high antibody titres (author's transl)]. Folia Vet Lat 1975; 5:353-72. [PMID: 1218850] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
|
11
|
Abstract
Experimental allergic neuritis was reproduced in chickens, by inoculation of chicken and guinea pig nerves in complete Freund's adjuvant. Paralysis was observed in a percentage of inoculated birds. Histopathologically this experimental autoimmune disease was characterized by severe demyelination of peripheral nerves in all experimental animals. In addition, oedema and/or lymphoid infiltration occurred in some of the animals. The similarity of experimental allergic neuritis to the inflammatory lesions of Marek's disease is stressed and the possible role of autoimmune processes in the pathogenesis of Marek's disease is discussed.
Collapse
|